[1] Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ[J]. Circulation, 2003, 108(14): 1664-72. [2] Prisant LM, Zemel PC, Nichols FT, et al. Carotid plaque associations among hypertensive patients[J]. Arch Inten Med, 1993, 153(4): 501-6. [3] Hennerici M, Reifschneider G, Trockel U, et al. Detect of early atherosclerotic lesions by duplex scanning of the carotid artery[J]. J Clin Ultrasound, 1984, 12: 455-6. [4] Crouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound[J]. Stroke, 1986, 17(2): 270-2. [5] Chimowitz MI, Weiss DG, Cohen SL. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease[J].Stroke, 1994, 25(4): 759-65. [6] Salonen JT, Salonen K. Ultersound B-mode imaging in observational studies of atherosclerotic progression[J]. Circulation, 1992, 23:947-51. [7] Ernest E. Fibrinogen as a cardiovascular risk factor; interrelationship with infection and inflammation[J]. Eur Heart J, 1993, 14(Suppl):k82-7. [8] Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesion of human coronary arteries[J].Arterioscler Throm Vasc Biol, 1998, 18(9): 1386-92. [9] Ridker PM, Henneken CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J]. N Eng J Med, 2000, 342(12): 836-43. [10] Haverkate F, Thomopson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997, 349(9050): 462-6. |